Biokarpet Statistics
Total Valuation
Biokarpet has a market cap or net worth of EUR 39.58 million. The enterprise value is 142.57 million.
Market Cap | 39.58M |
Enterprise Value | 142.57M |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
Earnings Date | Apr 25, 2025 |
Ex-Dividend Date | Aug 26, 2024 |
Share Statistics
Biokarpet has 23.99 million shares outstanding.
Shares Outstanding | 23.99M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 40.01% |
Owned by Institutions (%) | 10.74% |
Float | 14.39M |
Valuation Ratios
The trailing PE ratio is 11.85.
PE Ratio | 11.85 |
Forward PE | n/a |
PS Ratio | 0.20 |
PB Ratio | 0.81 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.93, with an EV/FCF ratio of -10.99.
EV / Earnings | 42.69 |
EV / Sales | 0.72 |
EV / EBITDA | 10.93 |
EV / EBIT | 19.91 |
EV / FCF | -10.99 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 2.21.
Current Ratio | 1.73 |
Quick Ratio | 1.09 |
Debt / Equity | 2.21 |
Debt / EBITDA | 8.61 |
Debt / FCF | -8.43 |
Interest Coverage | 0.98 |
Financial Efficiency
Return on equity (ROE) is 7.07% and return on invested capital (ROIC) is 2.69%.
Return on Equity (ROE) | 7.07% |
Return on Assets (ROA) | 2.04% |
Return on Capital (ROIC) | 2.69% |
Revenue Per Employee | 293,020 |
Profits Per Employee | 4,962 |
Employee Count | 676 |
Asset Turnover | 0.95 |
Inventory Turnover | 4.69 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.95% in the last 52 weeks. The beta is 0.99, so Biokarpet's price volatility has been similar to the market average.
Beta (5Y) | 0.99 |
52-Week Price Change | -19.95% |
50-Day Moving Average | 1.86 |
200-Day Moving Average | 2.43 |
Relative Strength Index (RSI) | 38.94 |
Average Volume (20 Days) | 2,238 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biokarpet had revenue of EUR 197.20 million and earned 3.34 million in profits. Earnings per share was 0.14.
Revenue | 197.20M |
Gross Profit | 31.67M |
Operating Income | 6.81M |
Pretax Income | 4.89M |
Net Income | 3.34M |
EBITDA | 11.45M |
EBIT | 6.81M |
Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 7.15 million in cash and 109.33 million in debt, giving a net cash position of -102.18 million or -4.26 per share.
Cash & Cash Equivalents | 7.15M |
Total Debt | 109.33M |
Net Cash | -102.18M |
Net Cash Per Share | -4.26 |
Equity (Book Value) | 49.42M |
Book Value Per Share | 2.03 |
Working Capital | 45.38M |
Cash Flow
In the last 12 months, operating cash flow was 3.31 million and capital expenditures -16.29 million, giving a free cash flow of -12.98 million.
Operating Cash Flow | 3.31M |
Capital Expenditures | -16.29M |
Free Cash Flow | -12.98M |
FCF Per Share | -0.54 |
Margins
Gross margin is 16.06%, with operating and profit margins of 3.46% and 1.69%.
Gross Margin | 16.06% |
Operating Margin | 3.46% |
Pretax Margin | 2.48% |
Profit Margin | 1.69% |
EBITDA Margin | 5.80% |
EBIT Margin | 3.46% |
FCF Margin | -6.58% |
Dividends & Yields
Biokarpet does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 8.44% |
FCF Yield | -32.79% |
Stock Splits
The last stock split was on March 15, 2000. It was a forward split with a ratio of 2.
Last Split Date | Mar 15, 2000 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Biokarpet has an Altman Z-Score of 1.39. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.39 |
Piotroski F-Score | n/a |